Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medexus Pharmaceuticals Inc
T.MDP
Alternate Symbol(s):
MEDXF
Healthcare
Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. Its focus is on the therapeutic areas of oncology, hematology, rheumatology, autoimmune diseases, allergy, and dermatology. It operates through two segments: Medexus Pharma Canada and Medexus Pharma USA. Its...
lead products are IXINITY (US), Rupall (Canada), Rasuvo (US) and Metoject (Canada), and Gleolan (US). IXINITY (US) is an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B. Rupall (Canada) is a prescription allergy medication with a mode of action. Rasuvo (US) and Metoject (Canada) is a formulation of methotrexate designed to treat rheumatoid arthritis and other autoimmune diseases. Gleolan (US) is an optical imaging agent indicated in patients with glioma as an adjunct for the visualization of malignant tissue during surgery.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MDP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Jul 09, 2021 10:25am
Doubled up
Can't believe the lack of post here. This stock is a flyer in Q3 and Q4. My previous post outlines how one analyst has Medexus as their #1 holding. Do you DD and find out why this one has a
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Jul 05, 2021 2:57pm
Write up in Yahoo
Mon, July 5, 2021, 6:00 AM ·2 min read Medexus Pharmaceuticals (Vancouver: MDP) (OTC: MEDXF) — a Top Pick for 2021 — is the rare company that is cheap on its current
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Jun 29, 2021 1:18pm
RE:Medexus gets Ok for Treosulfan in Canada
This is awesome news and should mean that the FDA approval is a done deal in August. Q4 (sept-dec) is going to be tremdous in terms of revenue.
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Jun 29, 2021 1:12pm
Medexus gets Ok for Treosulfan in Canada
https://www.globenewswire.com/news-release/2021/06/28/2254293/0/en/Medexus-Receives-Notice-of-Compliance-to-Commercialize-Treosulfan-in-Canada.html Ken d’Entremont, CEO, commented, “We are thrilled
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Jun 24, 2021 10:16am
RE:RE:RE:Insider Buying!!!
Makes you wonder who they heck was selling. Load up if you can at this price because the next stop up could be $20.
(2)
•••
oceaneleven
X
View Profile
View Bullboard History
Comment by
oceaneleven
on Jun 23, 2021 4:31pm
RE:RE:Insider Buying!!!
not just 1 insider but 5 insiders buying!!!!! This horse is about to run!!!!
(2)
•••
oceaneleven
X
View Profile
View Bullboard History
Comment by
oceaneleven
on Jun 23, 2021 12:35pm
RE:Insider Buying!!!
https://www.canadianinsider.com/company?ticker=MDP
(2)
•••
oceaneleven
X
View Profile
View Bullboard History
Post by
oceaneleven
on Jun 23, 2021 12:32pm
Insider Buying!!!
https://www.canadianinsider.com/company?ticker=MDP
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Jun 21, 2021 3:27pm
Gut check time... Nah!
Been here before and the selling is insane or shorts jumping in on the quarterlies. FDA approval is Aug 11, hopefully (not a certainty), then we are going higher.
(0)
•••
gjoseph22
X
View Profile
View Bullboard History
Comment by
gjoseph22
on Jun 17, 2021 3:28pm
RE:TIME ...
this is doing better than I thought would happen ... usually cost more on the TSX ... 6 weeks to August 11th is not that far away ...
(751)
•••
Finallytherock
X
View Profile
View Bullboard History
Comment by
Finallytherock
on Jun 17, 2021 2:28pm
RE:RE:RE:The Good outweighs the Bad in YE data
yeah, i'd like to see them on the nasdaq by the time treo is approved but not sure that will happen. i think being on the nasdaq is important but to be honest, i follow a few companies who just
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Jun 17, 2021 2:12pm
RE:RE:The Good outweighs the Bad in YE data
Agree. To bad about Nasdaq being dropped. Better for the company because of the cost and going on the Nasdaq. Once Treo is approved and cash is rolling in then they can consider it again.
(751)
•••
Finallytherock
X
View Profile
View Bullboard History
Comment by
Finallytherock
on Jun 17, 2021 12:28pm
RE:The Good outweighs the Bad in YE data
the numbers were okay. i expect there to some improvement next quarter. it's all about approval of treosulfan right now. it can more than double revenues for this company. once approved, i expect
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Jun 17, 2021 11:08am
The Good outweighs the Bad in YE data
When you read the Q4'21 you'll see that revenues were 800K less than year ago number. This can be a bummer but the real story for this company will be: Ken d’Entremont, Chief Executive
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Jun 16, 2021 4:15pm
RE:News uplist to toronto exchange june 17th
Sold half yesterday into the buys I'll add it back if the price goes lower than todays close in the near future.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >